Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene

被引:41
作者
Erichsen, Thomas J. [1 ]
Ehmer, Ursula [1 ]
Kalthoff, Sandra [1 ]
Lankisch, Tim O. [1 ]
Mueller, Tordis M. [1 ]
Munzel, Peter A. [2 ]
Manns, Michael P. [1 ]
Strassburg, Christian R. [1 ]
机构
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany
[2] Univ Tubingen, Dept Toxicol, Inst Pharmacol & Toxicol, Tubingen, Germany
关键词
UDP glucuronosyltransferase; transcriptional regulation; nuclear receptor; single nucleotide polymorphism; UGT1A4; xenobiotic response element;
D O I
10.1016/j.taap.2008.02.020
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP glucuronosyltransferases (UGTs) play an important role for drug detoxification and toxicity. UGT function is genetically modulated by single nuclecticle polymorphisms (SNPs) which lead to the expression of functionally altered protein, or altered expression levels. UGT1A4 activity includes anticonvulsants, antidepressants and environmental mutagens. In this study the induction of the human UGT1A4 gene and a potential influence of genetic variation in its promoter region were analyzed. SNPs at bp -219 and - 163 UGTI A4 i i i i b 40% transcr pt on was occurred in 9% among 109 blood donors reducing UGTlA4 transcr pt on y. dioxin inducible. Reporter gene experiments identified 2 xenobiotic response elements (XRE), which were functionally confirmed by mutagenesis analyses, and binding was demonstrated by electromobility shift assays. Constitutive human UGTIA4 gene expression and induction was aryl hydrocarbon receptor (AhR)dependent, and reduced in the presence ofSNPs at bp -219 and - 163. AhR-mediated regulation of the human UGTIA4 gene by two XRE and a modulation by naturally occurring genetic variability by SNPs is demonstrated, which indicates gene-environment interaction with potential relevance for drug metabolism. (c) 2008 Elsevier Inc. All rights reserved
引用
收藏
页码:252 / 260
页数:9
相关论文
共 41 条
[1]   UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan [J].
Ando, Y ;
Saka, H ;
Asai, G ;
Sugiura, S ;
Shimokata, K ;
Kamataki, T .
ANNALS OF ONCOLOGY, 1998, 9 (08) :845-847
[2]   Mechanism of rat UDP-glucuronosyltransferase 1A6 induction by oltipraz: Evidence for a contribution of the aryl hydrocarbon receptor pathway [J].
Auyeung, DJ ;
Kessler, FK ;
Ritter, JK .
MOLECULAR PHARMACOLOGY, 2003, 63 (01) :119-127
[3]   THE GENETIC-BASIS OF THE REDUCED EXPRESSION OF BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1 IN GILBERTS-SYNDROME [J].
BOSMA, PJ ;
CHOWDHURY, JR ;
BAKKER, C ;
GANTLA, S ;
DEBOER, A ;
OOSTRA, BA ;
LINDHOUT, D ;
TYTGAT, GNJ ;
JANSEN, PLM ;
ELFERINK, RPJO ;
CHOWDHURY, NR .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (18) :1171-1175
[4]   Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus [J].
Chen, SJ ;
Beaton, D ;
Nguyen, N ;
Senekeo-Effenberger, K ;
Brace-Sinnokrak, E ;
Argikar, U ;
Remmel, RP ;
Trottier, J ;
Barbier, O ;
Ritter, JK ;
Tukey, RH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (45) :37547-37557
[5]   Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor [J].
Chen, YH ;
Tukey, RH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) :26261-26266
[6]   Variation of hepatic glucuronidation:: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4 [J].
Ehmer, U ;
Vogel, A ;
Schütte, JK ;
Krone, B ;
Manns, MP ;
Strassburg, CP .
HEPATOLOGY, 2004, 39 (04) :970-977
[7]  
Emi Y, 1996, J BIOL CHEM, V271, P3952, DOI 10.1074/jbc.271.7.3952
[8]   Distribution and inducibility by 3-methylcholanthrene of family 1 UDP-glucuronosyltransferases in the rat gastrointestinal tract [J].
Grams, B ;
Harms, A ;
Braun, S ;
Strassburg, CP ;
Manns, MP ;
Obermayer-Straub, P .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 377 (02) :255-265
[9]  
Green MD, 1996, DRUG METAB DISPOS, V24, P356
[10]   Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus:: functional consequences of three novel missense mutations in the human UGT1A7 gene [J].
Guillemette, C ;
Ritter, JK ;
Auyeung, DJ ;
Kessler, FK ;
Housman, DE .
PHARMACOGENETICS, 2000, 10 (07) :629-644